Accumulation of CTLA-4 expressing T lymphocytes in the germinal centres of human lymphoid tissues

被引:25
作者
Castan, J [1 ]
TennerRacz, K [1 ]
Racz, P [1 ]
Fleischer, B [1 ]
Broker, BM [1 ]
机构
[1] BERNHARD NOCHT INST TROP MED,D-20359 HAMBURG,GERMANY
关键词
D O I
10.1046/j.1365-2567.1997.00162.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CTLA-4, a coreceptor with sequence homology to CD28 is expressed on T cells after activation. Mice deficient for CTLA-4 die young from massive infiltration of many organs by activated T cells, which highlights the essential inhibitory role the coreceptor plays in the regulation of the immune response. To study the prevalence and distribution of CTLA-4 in situ immunohistological analyses were carried out on human tonsils and lymph nodes. Expression of CTLA-4 was restricted to alpha beta T cells, and CTLA-4(+) B cells were not observed. In T-cell areas, 2-10% of T cells were positive for CTLA-4 with similar percentages in the CD4(+) and CD8(+) subpopulations. In the germinal centres (GC) the fraction of CTLA-4(+) T cells was much higher (70-90%). This was due to frequent expression of CTLA-4 on the CD4(+) helper subpopulation. GC CD8(+) T cells were rare and mostly did not express the coreceptor. The CTLA-4(+) T-cell fraction was also over-represented among intraepithelial tonsillar T cells. Cycling (Ki-67(+)) and apoptotic (TUNEL(+)) T cells were never positive for CTLA-4, while a subset of CD25(+) cells did express the coreceptor. Since CTLA-4 is essential for the physiological limitation of the immune response, GC T cells, which are mostly CTLA-4 positive, might be important in this process.
引用
收藏
页码:265 / 271
页数:7
相关论文
共 36 条
[21]   Enhancement of antitumor immunity by CTLA-4 blockade [J].
Leach, DR ;
Krummel, MF ;
Allison, JP .
SCIENCE, 1996, 271 (5256) :1734-1736
[22]   HUMAN B7-1 (CD80) AND B7-2 (CD86) BIND WITH SIMILAR AVIDITIES BUT DISTINCT KINETICS TO CD28 AND CTLA-4 RECEPTORS [J].
LINSLEY, PS ;
GREENE, JL ;
BRADY, W ;
BAJORATH, J ;
LEDBETTER, JA ;
PEACH, R .
IMMUNITY, 1994, 1 (09) :793-801
[23]   DISTINCT ROLES FOR CD28 AND CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED MOLECULE-4 RECEPTORS DURING T-CELL ACTIVATION [J].
LINSLEY, PS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (02) :289-292
[24]   CTLA-4 IS A 2ND RECEPTOR FOR THE B-CELL ACTIVATION ANTIGEN-B7 [J].
LINSLEY, PS ;
BRADY, W ;
URNES, M ;
GROSMAIRE, LS ;
DAMLE, NK ;
LEDBETTER, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (03) :561-569
[25]   COEXPRESSION AND FUNCTIONAL COOPERATION OF CTLA-4 AND CD28 ON ACTIVATED LYMPHOCYTES-T [J].
LINSLEY, PS ;
GREENE, JL ;
TAN, P ;
BRADSHAW, J ;
LEDBETTER, JA ;
ANASETTI, C ;
DAMLE, NK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (06) :1595-1604
[26]   CLONAL EXPANSION VERSUS FUNCTIONAL CLONAL INACTIVATION - A COSTIMULATORY SIGNALING PATHWAY DETERMINES THE OUTCOME OF T-CELL ANTIGEN RECEPTOR OCCUPANCY [J].
MUELLER, DL ;
JENKINS, MK ;
SCHWARTZ, RH .
ANNUAL REVIEW OF IMMUNOLOGY, 1989, 7 :445-480
[27]   COMPLEMENTARITY-DETERMINING REGION-1 (CDR1)-ANALOGOUS AND CDR3-ANALOGOUS REGIONS IN CTLA-4 AND CD28 DETERMINE THE BINDING TO B7-1 [J].
PEACH, RJ ;
BAJORATH, J ;
BRADY, W ;
LEYTZE, G ;
GREENE, J ;
NAEMURA, J ;
LINSLEY, PS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06) :2049-2058
[28]  
POPPEMA S, 1983, CLIN EXP IMMUNOL, V54, P834
[29]   CD28-B7 BLOCKADE AFTER ALLOANTIGENIC CHALLENGE IN-VIVO INHIBITS TH1 CYTOKINES BUT SPARES TH2 [J].
SAYEGH, MH ;
AKALIN, E ;
HANCOCK, WW ;
RUSSELL, ME ;
CARPENTER, CB ;
LINSLEY, PS ;
TURKA, LA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05) :1869-1874
[30]   LYMPHOCYTES - THE ULTIMATE COMPUTERS [J].
SWAIN, SL ;
RETH, M .
CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (03) :355-358